JOHNSON & JOHNSON

Holdings History for Protagonist Therapeutics, Inc - Common Stock, $0.00001 par value (PTGX)

Symbol: PTGX on Nasdaq
Investment type: Equity / Common Stock, $0.00001 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Price	All Holders
31 Dec 2025	39%	0%	$213,911,643	2,449,183	$87.34	Q4 2025
30 Sep 2025	32%	0%	$162,699,227	2,449,183	$66.43	Q3 2025
30 Jun 2025	41%	0%	$136,395,001	2,449,183	$55.69	Q2 2025
31 Mar 2025	35%	0%	$118,442,490	2,449,183	$48.36	Q1 2025
31 Dec 2024	24%	0%	$94,538,464	2,449,183	$38.60	Q4 2024
30 Sep 2024	26%	0%	$110,213,235	2,449,183	$45.00	Q3 2024
30 Jun 2024	21%	0%	$84,864,191	2,449,183	$34.65	Q2 2024
31 Mar 2024	1.6%	0%	$70,854,864	2,449,183	$28.93	Q1 2024
31 Dec 2023	1.3%	0%	$56,159,766	2,449,183	$22.93	Q4 2023
30 Sep 2023	15%	0%	$40,852,372	2,449,183	$16.68	Q3 2023
30 Jun 2023	21%	0%	$67,646,434	2,449,183	$27.62	Q2 2023
31 Mar 2023	18%	0%	$56,331,209	2,449,183	$23.00	Q1 2023
31 Dec 2022	7.8%	0%	$26,721,000	2,449,183	$10.91	Q4 2022
30 Sep 2022	6.1%	0%	$20,647,000	2,449,183	$8.43	Q3 2022
30 Jun 2022	4.9%	0%	$19,373,000	2,449,183	$7.91	Q2 2022
31 Mar 2022	11%	0%	$57,997,000	2,449,183	$23.68	Q1 2022
31 Dec 2021	9.5%	0%	$83,762,000	2,449,183	$34.20	Q4 2021
30 Sep 2021	3.8%	0%	$43,400,000	2,449,183	$17.72	Q3 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.